AIM IMMUNOTECH INC.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $367.0K | $437.0K | $92.0K | $133.0K | $197.0K | $150.0K | $213.0K | $161.0K |
| Cost of Revenue | — | — | — | — | $1.3M | $1.2M | $2.0M | $1.0M |
| Gross Profit | — | — | — | — | $-1.1M | $-1.1M | $-1.8M | $-882.0K |
| Gross Margin | — | — | — | — | -535.0% | -722.7% | -833.8% | -547.8% |
| Operating Expenses | ||||||||
| Research & Development | $4.8M | $4.1M | $5.1M | $8.0M | $9.0M | $8.4M | $9.5M | $6.7M |
| SG&A Expense | $6.2M | $6.6M | $7.7M | $7.1M | $9.1M | $7.7M | $9.1M | $6.7M |
| Operating Income | $-11.5M | $-11.4M | $-13.8M | $-16.7M | $-19.1M | $-17.2M | $-20.3M | $-14.3M |
| Operating Margin | -3,132.4% | -2,612.4% | -15,004.3% | -12,518.8% | -9,694.9% | -11,444.7% | -9,549.3% | -8,878.9% |
| Interest Expense | $201.0K | — | — | $3.0K | $11.0K | $16.0K | $24.0K | $41.0K |
| Pretax Income | — | — | — | — | — | — | — | — |
| Income Tax Expense | — | — | — | — | — | — | — | — |
| Net Income | $-9.8M | $-8.3M | $-7.5M | $-15.2M | $-17.5M | $-16.2M | $-17.4M | $-9.0M |
| Net Margin | -2,677.7% | -1,889.9% | -8,154.3% | -11,451.1% | -8,857.9% | -10,816.7% | -8,147.4% | -5,599.4% |
| EPS (Basic) | $-3.26 | $-0.10 | $-0.11 | $-0.26 | $-0.37 | $-0.03 | $-0.04 | $-0.02 |
| EPS (Diluted) | $-3.26 | $-0.10 | $-0.11 | $-0.26 | $-0.37 | $-0.03 | $-0.04 | $-0.02 |
| Shares Outstanding (Basic) | 3.3M | 98.7M | 72.6M | 61.9M | 612.0M | 506.0M | 499.5M | 406.9M |
| Shares Outstanding (Diluted) | 3.3M | 98.7M | 72.6M | 61.9M | 612.0M | 506.0M | 499.5M | 406.9M |
| Dividends Per Share | — | — | — | — | — | — | — | — |